Recurrent Colon Cancer [clinicaltrials_resource:dc677c5021b8cec5e9728d6753ff45c3]
Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer [clinicaltrials:NCT00002796]Antineoplaston Therapy in Treating Patients With Colon Cancer [clinicaltrials:NCT00003486]Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer [clinicaltrials:NCT00003873]Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [clinicaltrials:NCT00004074]Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer [clinicaltrials:NCT00005036]SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer [clinicaltrials:NCT00005818]Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer [clinicaltrials:NCT00019006]Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver [clinicaltrials:NCT00019760]Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer [clinicaltrials:NCT00023933]Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated [clinicaltrials:NCT00025337]Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver [clinicaltrials:NCT00026234]Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer [clinicaltrials:NCT00028496]Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction [clinicaltrials:NCT00030498]7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) [clinicaltrials:NCT00031681]Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer [clinicaltrials:NCT00032110]Imatinib Mesylate in Treating Patients With Stage IV Colorectal Cancer [clinicaltrials:NCT00041340]Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer [clinicaltrials:NCT00052585]A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer [clinicaltrials:NCT00060411]Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer [clinicaltrials:NCT00070122]Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal Cancer [clinicaltrials:NCT00070265]Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer [clinicaltrials:NCT00077298]GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors [clinicaltrials:NCT00084643]EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer [clinicaltrials:NCT00087191]Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer [clinicaltrials:NCT00088933]Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors [clinicaltrials:NCT00089362]Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment [clinicaltrials:NCT00091182]clinicaltrials:NCT00100841Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas [clinicaltrials:NCT00101270]Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer [clinicaltrials:NCT00101348]clinicaltrials:NCT00103311Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer [clinicaltrials:NCT00134069]Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors [clinicaltrials:NCT00138177]Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer [clinicaltrials:NCT00397384]clinicaltrials:NCT00397878VEGF Trap in Treating Patients With Previously Treated Metastatic Colorectal Cancer [clinicaltrials:NCT00407654]clinicaltrials:NCT00499369clinicaltrials:NCT00504153clinicaltrials:NCT00551421Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery [clinicaltrials:NCT00645710]clinicaltrials:NCT00754494
condition [clinicaltrials_vocabulary:condition]
Recurrent Colon Cancer [clinicaltrials_resource:dc677c5021b8cec5e9728d6753ff45c3]
Bio2RDF identifier
dc677c5021b8cec5e9728d6753ff45c3
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:dc677c5021b8cec5e9728d6753ff45c3
identifier
clinicaltrials_resource:dc677c5021b8cec5e9728d6753ff45c3
title
Recurrent Colon Cancer
@en
label
Recurrent Colon Cancer [clinicaltrials_resource:dc677c5021b8cec5e9728d6753ff45c3]
@en